drugset / Trial / NCT02358499

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

NCT02358499

Phase 1 Completed 31 enrolled Children's Mercy Hospital Kansas City
NaSingle-groupOpen-labelOther

Summary

The main goal of this study is to see how the body breaks down an antifungal drug named posaconazole in children with certain cancers, blood disorders, or transplantation of bone marrow or similar blood cells. This study will also help us learn whether a child's age, genetics, or disease affect how well the body breaks down posaconazole.

Timeline

Start
2015-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Posaconazole Small molecule Intravenous